The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Vistra ITCL (India) Ltd
SMSPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
SMS Pharmaceuticals Ltd has informed the exchanges about a disclosure filed by Vistra ITCL (India) Ltd in its capacity as Debenture Trustee under SEBI's Takeover Regulations. The filing reveals that 30,00,000 equity shares (3.38% of the company's share capital) were pledged on August 20, 2025. With this new pledge, Vistra's total encumbered (pledged) holding in SMS Pharmaceuticals increased from 1,90,86,740 shares (21.53%) to 2,20,86,740 shares (24.91%). Vistra is not part of the promoter/promoter group of the company. The total equity share capital of SMS Pharmaceuticals remains unchanged at 8,86,52,030 shares of Re. 1 each. The filing notes that the primary obligation to comply with SAST Regulations lies with the lender/debenture holder, and Vistra is filing this out of abundant caution.
This is a pledge-creation event where additional SMS Pharma shares have been offered as collateral to a debenture trustee. It does not represent any change in ownership or promoter stake, but retail investors should monitor whether rising pledged holdings could indicate increased financial stress on the pledging entity, as large-scale pledge invocations can create downward pressure on the stock.